Can't Miss Webinar—Lupus Nephritis: The ACR Guideline in Practice

An official publication of the ACR and the ARP serving rheumatologists and rheumatology professionals

  • Conditions
    • Axial Spondyloarthritis
    • Gout and Crystalline Arthritis
    • Myositis
    • Osteoarthritis and Bone Disorders
    • Pain Syndromes
    • Pediatric Conditions
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
    • Systemic Sclerosis
    • Vasculitis
    • Other Rheumatic Conditions
  • FocusRheum
    • ANCA-Associated Vasculitis
    • Axial Spondyloarthritis
    • Gout
    • Lupus Nephritis
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
  • Guidance
    • Clinical Criteria/Guidelines
    • Ethics
    • Legal Updates
    • Legislation & Advocacy
    • Meeting Reports
      • ACR Convergence
      • Other ACR meetings
      • EULAR/Other
    • Research Rheum
  • Drug Updates
    • Analgesics
    • Biologics/DMARDs
  • Practice Support
    • Billing/Coding
    • EMRs
    • Facility
    • Insurance
    • Technology
      • Information Technology
      • Apps
    • QA/QI
    • Workforce
  • Opinion
    • Patient Perspective
    • Profiles
    • Rheuminations
      • Video
    • Speak Out Rheum
  • Career
    • ACR ExamRheum
    • Awards
    • Career Development
      • Education & Training
    • Certification
  • ACR
    • ACR Home
    • ACR Convergence
    • ACR Guidelines
    • Journals
      • ACR Open Rheumatology
      • Arthritis & Rheumatology
      • Arthritis Care & Research
    • From the College
    • Events/CME
    • President’s Perspective
  • Search

Search results for: axial spondyloarthritis

What’s New in Inflammatory Arthritis?

Thomas R. Collins  |  June 1, 2014

Rheumatology experts at the ACR’s State-of-the-Art Clinical Symposium in Chicago discuss latest drug therapies, insights into axial spondyloarthritis and bone erosion, repair

Filed under:Axial SpondyloarthritisBiologics/DMARDsConditionsDrug UpdatesRheumatoid Arthritis Tagged with:AC&RadalimumabAmerican College of Rheumatology (ACR)BiosimilarsCollinsdruginfliximabMethotrexateradiographRheumatoid arthritistocilizumab

Workforce Solutions

Mithu Maheswaranathan, MD  |  November 14, 2025

Three experts discussed novel and practical strategies and resources that rheumatology clinics can use to improve the referral process, screening times and patients access to care.

Filed under:ACR ConvergenceMeeting ReportsPractice Support Tagged with:ACR Convergence 2025eConsultPractice ManagementPrimary Care PhysiciansreferralsWorkforce

Advances in Giant Cell Arteritis

Philip Seo, MD, MHS  |  November 14, 2025

Dr. Philip Seo highlights the latest research into the assessment and treatment of giant cell arteritis presented during ACR Convergence 2025.

Filed under:ACR ConvergenceConditionsMeeting ReportsVasculitis Tagged with:AAV FocusRheumACR Convergence 2025ANCA-Associated Vasculitisgiant cell arteritis (GCA)GlucocorticoidsimagingMagnetic resonance imaging (MRI)taperingupadacitinib

What’s New in Psoriatic Arthritis?

David Pisetsky, MD, PhD  |  October 28, 2025

Dr. David Pisetsky curated the research presented at ACR Convergence 2025 and answers the question “What new research on psoriatic arthritis has the potential to impact patient care or future research?”

Filed under:ACR ConvergenceConditionsMeeting ReportsPsoriatic Arthritis Tagged with:ACR Convergence 2025ACR Convergence 2025 - PsAAxial Psoriatic Arthritis (axPsA)inflammatory bowel disease (IBD)Obesity

The 2025 ACR Awards of Distinction

Patrice Fusillo  |  October 25, 2025

The ACR honors excellence in rheumatology. Meet the 2025 Awards of Distinction recipients, ACR Masters & Distinguished Fellows recognized at ACR Convergence 2025.

Filed under:ACR ConvergenceAwardsCareerMeeting Reports Tagged with:ACR Convergence 2025ACR MastersDistinguished Clinical Investigatordistinguished fellowHenry Kunkel Young Investigator AwardhonorsPresidential Gold Medal

New Research at ACR Convergence 2025 Demonstrates Impact of RISE Registry Data on Rheumatology Outcomes

From the College  |  October 19, 2025

New research presented at ACR Convergence 2025 highlights how the Rheumatology Informatics System for Effectiveness (RISE) Registry—the nation’s largest collection of electronic health record data from rheumatology practices—is driving transformative improvements in quality, safety and outcomes in patients with rheumatic and musculoskeletal diseases. Research studies reveal that participation in and engagement with RISE not only…

Filed under:ACR Convergence Tagged with:ACR Convergence 2025Rheumatology Informatics System for Effectiveness (RISE) Registry

Insights from an Orthopedic Spine Surgeon

Jason Liebowitz, MD, FACR  |  October 8, 2025

Dr. Jay Reidler, an adult & pediatric orthopedic spine surgeon, shares insights from his field & discusses his collaborations with rheumatologists.

Filed under:Axial SpondyloarthritisConditionsInterprofessional PerspectivePain SyndromesPractice SupportTechnology Tagged with:Back paincollaborationorthopedic surgerypain anagementPhysical TherapySpinal Stenosisspinespondyloarthritissurgery

Key Research in Vasculitis Encapsulated

Philip Seo, MD, MHS  |  August 6, 2025

Summaries of selected research abstracts on the assessment & management of systemic vasculitis from ACR Convergence 2024.

Filed under:ACR ConvergenceConditionsMeeting ReportsResearch RheumVasculitis Tagged with:AAV FocusRheumACR Convergence 2024DADA2eosinophilic granulomatosis with polyangiitis (EGPA)Giant Cell ArteritisGlucocorticoidsgranulomatosis with polyangiitisIgG4 related diseaseinebilizumabInterleukinJAK inhibitormepolizumabupadacitinibVasculitis

JAK Inhibitors 101

Jason Liebowitz, MD, FACR  |  July 28, 2025

Experts provided an in-depth review of Janus kinase (JAK) inhibitors, discussing the latest research on their use in the treatment of specific rheumatic conditions, the risks associated with them and more.

Filed under:Biologics/DMARDsConditionsDrug UpdatesEULAR/OtherGuidanceMeeting Reports Tagged with:EULAR 2025JAK inhibitorsJanus Kinase Inhibitors

Finding the Panacea: The Management of Psoriatic Arthritis

Jason Liebowitz, MD, FACR  |  July 16, 2025

In a session at EULAR 2025, Dr. Laura Coates discussed the management of PsA, providing insights into the current research and when clinicians may want to consider prescribing specific medications.

Filed under:ConditionsEULAR/OtherGuidanceMeeting ReportsPsoriatic Arthritis Tagged with:Axial Psoriatic Arthritis (axPsA)EULAR 2025PsAPsA Resource Centerpsoriatic arthritisskin

  • « Previous Page
  • 1
  • …
  • 6
  • 7
  • 8
  • 9
  • 10
  • …
  • 20
  • Next Page »
  • About Us
  • Meet the Editors
  • Issue Archives
  • Contribute
  • Advertise
  • Contact Us
  • Copyright © 2026 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies. ISSN 1931-3268 (print). ISSN 1931-3209 (online).
  • DEI Statement
  • Privacy Policy
  • Terms of Use
  • Cookie Preferences